Transduction of cytotoxic signals in natural killer cells: A general model of fine tuning between activatory and inhibitory pathways in lymphocytes

被引:96
作者
Renard, V [1 ]
Cambiaggi, A [1 ]
Vely, F [1 ]
Blery, M [1 ]
Olcese, L [1 ]
Olivero, S [1 ]
Bouchet, M [1 ]
Vivier, E [1 ]
机构
[1] CNRS MARSEILLE LUMINY, CTR IMMUNOL, INSERM, F-13288 MARSEILLE 09, FRANCE
关键词
D O I
10.1111/j.1600-065X.1997.tb00953.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NK-cells are large granular lymphocytes, which are capable of exerting two major types of effector function, cell cytotoxicity and lymphokine secretion. NK-cells can exert cell cytotoxicity in one of two ways. First, NK-cells are able to recognize and to induce the lysis of antibody-coated target cells during antibody-dependent cell cytotoxicity (ADCC). Second, during natural cytotoxicity NK-cells are also able to recognize and to induce the lysis of a variety of target cells, including primarily virus-infected cells as well as tumor cells. Recently, a novel mechanism has been elucidated which controls NK-cell-activation programs and which is based on the cell surface expression of killer-cell inhibitory receptors (KIR). We will review here the molecular dissection of this inhibitory signalling pathway which utilizes immunoreceptor tyrosine-based inhibition motifs (ITIM) expressed in KIR intracytoplasmic domain. We will also show that this strategy used by NK-cells to regulate their effector functions is a general decision mechanism which exists not only in T- and B-lymphocytes, but also in a variety of other hematopoietic cells.
引用
收藏
页码:205 / 221
页数:17
相关论文
共 153 条
  • [1] CYTOPLASMIC DOMAIN HETEROGENEITY AND FUNCTIONS OF IGG FC-RECEPTORS IN LYMPHOCYTES-B
    AMIGORENA, S
    BONNEROT, C
    DRAKE, JR
    CHOQUET, D
    HUNZIKER, W
    GUILLET, JG
    WEBSTER, P
    SAUTES, C
    MELLMAN, I
    FRIDMAN, WH
    [J]. SCIENCE, 1992, 256 (5065) : 1808 - 1812
  • [2] FC-GAMMA RECEPTOR TYPE-III (CD16) IS INCLUDED IN THE ZETA-NK RECEPTOR COMPLEX EXPRESSED BY HUMAN NATURAL-KILLER-CELLS
    ANDERSON, P
    CALIGIURI, M
    OBRIEN, C
    MANLEY, T
    RITZ, J
    SCHLOSSMAN, SF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) : 2274 - 2278
  • [3] INTERACTION OF FC-RECEPTOR (CD16) LIGANDS INDUCES TRANSCRIPTION OF INTERLEUKIN-2 RECEPTOR (CD25) AND LYMPHOKINE GENES AND EXPRESSION OF THEIR PRODUCTS IN HUMAN NATURAL-KILLER CELLS
    ANEGON, I
    CUTURI, MC
    TRINCHIERI, G
    PERUSSIA, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (02) : 452 - 472
  • [4] Interferon gamma production by natural killer (NK) cells and NK1.1(+) T cells upon NKR-P1 cross-linking
    Arase, H
    Arase, N
    Saito, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) : 2391 - 2396
  • [5] ARM JP, 1991, J BIOL CHEM, V266, P15966
  • [6] IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS
    AUPHAN, N
    DIDONATO, JA
    ROSETTE, C
    HELMBERG, A
    KARIN, M
    [J]. SCIENCE, 1995, 270 (5234) : 286 - 290
  • [7] STIMULATION OF FC-GAMMA-RIIIA RESULTS IN PHOSPHOLIPASE C-GAMMA-1 TYROSINE PHOSPHORYLATION AND P56(LCK) ACTIVATION
    AZZONI, L
    KAMOUN, M
    SALCEDO, TW
    KANAKARAJ, P
    PERUSSIA, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) : 1745 - 1750
  • [8] CHARACTERIZATION OF THE LYMPHOCYTE-ACTIVATION GENE 3-ENCODED PROTEIN - A NEW LIGAND FOR HUMAN-LEUKOCYTE ANTIGEN CLASS-II ANTIGENS
    BAIXERAS, E
    HUARD, B
    MIOSSEC, C
    JITSUKAWA, S
    MARTIN, M
    HERCEND, T
    AUFFRAY, C
    TRIEBEL, F
    PIATIERTONNEAU, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (02) : 327 - 337
  • [9] BEZOUSKA K, 1994, J BIOL CHEM, V269, P16945
  • [10] The human leukocyte antigen (HLA)-C-specific ''activatory'' or ''inhibitory'' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions
    Biassoni, R
    Cantoni, C
    Falco, M
    Verdiani, S
    Bottino, C
    Vitale, M
    Conte, R
    Poggi, A
    Moretta, A
    Moretta, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) : 645 - 650